Tomorrow, July 23 at 11:10 am, Sriram Subramaniam will present his talk, Cryo-EM, AI, and Drug Discovery, at The Protein Society Annual Symposium in Vancouver. https://lnkd.in/gh-UUUFu #ps38
About us
PROGENITER is a University of British Columbia-affiliated, nationally recognized, multi-year research program to enable the rapid design, engineering, and production of antibody leads against present and future viral diseases to ensure that Canada is better prepared for the next pandemic. PROGENITER is a key component of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH).
- Website
-
https://progeniter.ca/
External link for PROGENITER
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Nonprofit
Updates
-
Congratulations to #PROGENITER Director Sriram Subramaniam, who was awarded a 2024 Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant for his project, "On-Grid Purification of Biomolecules for Electron Microscopy."
Over $36m awarded to UBC Researchers through NSERC 2024 Discovery Research Program
research.ubc.ca
-
Congratulations to Dr. Eric Jan and Dr. Annie Vogel Ciernia, PROGENITER team members who were awarded Distinguished Achievement Awards from the Faculty of Medicine at the University of British Columbia! Dr. Jan was recognized for Excellence in Basic Science Research, and Dr. Ciernia was recognized for Advancement of Equity, Diversity and Inclusiveness through research, teaching and service. #EDI #awards #CIEBH
2024 Faculty of Medicine Distinguished Achievement Award Recipients - UBC Faculty of Medicine
https://www.med.ubc.ca
-
PROGENITER reposted this
CEO, Gandeeva Therapeutics and Gobind Khorana Canada Excellence Research Chair, Precision Cancer Drug Design, University of British Columbia
Exciting times at The University of British Columbia!
Last week, MP Randeep Sarai joined The University of British Columbia and its partners to announce $140M for Canada’s Immuno-Engineering & Biomanufacturing Hub. Explore how this will bolster Canada’s biotech sector and pandemic readiness. ➡️ bit.ly/4aH53N1 - #Biomedicine #Immunoengineering #BCLifeSciences
-
-
PROGENITER reposted this
CEO, Gandeeva Therapeutics and Gobind Khorana Canada Excellence Research Chair, Precision Cancer Drug Design, University of British Columbia
I am delighted to be leading PROGENITER, one of the four projects that are part of #UBC-led $140M initiative to leverage BC’s academic and biosciences industry strengths to the develop novel treatments for the next viral threat to improve health outcomes for Canadians. We are excited to join forces with partners in industry including Gandeeva Therapeutics, Amgen, AbCellera, GSK and Zymeworks Inc. Thanks to Sean Silcoff and The Globe and Mail for highlighting this exciting milestone.
B.C. drug developers get boost with government funding for new manufacturing facility
theglobeandmail.com
-
We are thankful for the support of the Government of Canada, Innovation, Science and Economic Development Canada, Canada's Immuno-Engineering and Biomanufacturing Hub (#CIEBH), and The University of British Columbia as we launch PROGENITER. PROGENITER is an academic-industry partnership linking researchers and innovators across BC’s life sciences ecosystem to create a suite of ready-to-deploy antibody treatments to ensure that Canada is ready to respond quickly to the next pandemic. Learn more at https://progeniter.ca
Today, Randeep Sarai and Benoit-Antoine Bacon celebrated $140M in Canadian Science funding for projects that will advance the development of life-saving medicines as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) led by UBC. The funding supports four multidisciplinary research projects through CIEBH, a UBC-led alliance of more than 50 academic, industry, not-for-profit and health system partners that have come together to make Canada a leader in advanced immune-based therapeutics like RNA vaccines, antibody treatments and cell therapies. Collectively, the projects aim to establish an end-to-end drug development pipeline that will enable Canada to mount a rapid 100-day response to emerging pandemic threats and other health challenges. Read more: https://bit.ly/3X5C3M4 #cdnpoli #cdned
-